08 (3) SEP - 15 SEP 2022 (studied 12 JAN 2023) Flashcards
a ____________________ is the best incision to use to gain access to the carina and proximal left mainstem bronchus
right posterolateral thoracotomy
most common incision for open repair of a left congenital diaphragmatic hernia?
left subcostal
consensus guidelines suggest a safe FLR% of __-__% for patients with normal liver parenchyma, __-__% for those who have steatosis or have received chemotherapy, and more than ___% for those who have underlying cirrhosis
- 20-30%
- 30-40%
- 40+%
ideal length of a J pouch?
15-20 cm
most of the colonic absorption of fluids and electrolytes occurs in the:
ascending colon
most patients with pouchitis respond to treatment with:
flagyl
recently updated guidelines also suggest PO _________ as an alternative to PO vancomycin for c. diff colitis
fidaxomicin
routine monitoring of serum ___________ levels should be performed in all patients who undergo a hemithyroidectomy
thyrotropin (TSH)
in determining the cause of steatorrhea, <__g of fecal fat is consistent with an intestinal etiology, whereas >__g of fecal fat is consistent with pancreatic insufficiency
- 20 g
- 20 g
treatment for all stages of anal squamous cell cancer is:
chemoradiation
the modified Nigro regimen that is currently used consists of:
5-fluorouracil, mitomycin C, and pelvic radiation therapy with 50 Gy to the primary carcinoma and 35 to 45 Gy to the pelvic inguinal lymph nodes
calculation of functional liver remnant (FLR):
FLR% = FLR ÷ (total liver volume – tumor volume)
Pembrolizumab is a monoclonal antibody against ____ and has significantly increased long-term survival, up to 40% or more, for patients with metastatic melanoma
PD-1
_________________ is a monoclonal antibody against PD-1 and has significantly increased long-term survival, up to 40% or more, for patients with metastatic melanoma
Pembrolizumab
Pembrolizumab is a monoclonal antibody against PD-1 and has significantly increased long-term survival, up to 40% or more, for patients with ________________
metastatic melanoma